Tumor necrosis factor-alpha levels after surgical anti-infective mechanical theraphy for peri-implantitis: A 12-month follow-up

Journal of Periodontology

Volumn 80, Issue 4, 2009, Pages 693-699

  De Mendonga, Adrlana Cutrim ^a   Santos, Vanessa Renata ^a   Cesar Neto, João Batista ^b   Duarte, Pollana Mendes ^a,c  

^a GUARULHOS UNIVERSITY   (Brazil)

^b FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^c Rua Dr Nilo P anha   (Brazil)

Author keywords

Cytokines; Dental Implants; Tumor necrosis factor alpha

Indexed keywords

CHLORHEXIDINE; CHLORHEXIDINE GLUCONATE; DRUG DERIVATIVE; MOUTHWASH; TOPICAL ANTIINFECTIVE AGENT; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; CASE REPORT; CHEMISTRY; DEBRIDEMENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVITIS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PERIODONTICS; PERIODONTITIS; TOOTH IMPLANTATION;

AGED; ANTI-INFECTIVE AGENTS, LOCAL; CHLORHEXIDINE; DEBRIDEMENT; DENTAL IMPLANTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; MALE; MIDDLE AGED; MOUTHWASHES; PERIODONTAL INDEX; PERIODONTITIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 63849164092     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2009.080521     Document Type: Article

References (35)

1. Berglundh T, Persson L, KHnge B. A systematic review of the incidence of biological and technical complications in implant dentistry reported in prospective longitudinal studies of at least 5 years. J Clin Periodontal 2002;29:197-212.
2. Hultin M, Gustafsson A, Hallstrom H, Johansson LA, Ekfeldt A, Klinge B. Microbiological findings and host response in patients with peri-implantitis. Clin Oral Implants Res 2002;13:349-358.
3. Botero JE, Gonzalez AM, Mercado RA, Olave G, Contreras A. Subgingival microbiota in peri-implant mucosa lesions and adjacent teeth in partially edentulous patients. J Periodontal 2005;76:1490-1495.
4. Seymour GJ, Gemmell E. Cytokines in periodontal disease: Where to from here? Acta Odontol Scand 2001:59:167-173.
5. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007;449: 819-826.
6. Wajant H, Pfeffer K, Pfizenmaier K, Scheurich P. Tumor necrosis factors in 1998. Cytokine Growth Factor Reu 1998;9:297-302.
7. Boyce BF, Li P, Yao Z, et al. TNF-alpha and pathologic bone resorption. Keio J Med 2005;54:127-131.
8. Rossomando EF, Kennedy JE, Hadjimichael J. Tumour necrosis factor alpha in gingival crevicular fluid as a possible indicator of periodontal disease in humans. Arch Oral Biol 1990;35:431-434.
9. Kurti B, Tüter G, Serdar M, et al. Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis. J Periodontal 2005;76:1849-1855.
10. Ikezawa I, Tai H, Shimada Y, Komatsu Y, Galicia JC, Yoshie H. Imbalance between soluble tumour necrosis factor receptors type 1 and 2 in chronic periodontitis. J Clin Periodontol 2005;32:1047-1054,
11. Silva N, Dutzan N, Hernandez M, et al. Characterization of progressive periodontal lesions in chronic periodontitis patients: Levels of chemokines, cytokines, matrix metalloproteinase-13, periodontal pathogens and inflammatory cells. J Clin Periodontol 2008;35:206-214.
12. Erdemir EO, Duran I, Haliloglu S. Effects of smoking on clinical parameters and the gingival crevicular fluid levels of IL-6 and TNF-alpha in patients with chronic periodontitis. J Clin Periodontol 2004;31:99-104.
13. Navarro-Sanchez AB, Paria-Almeida R, Bascones-Martinez A. Effect of non-surgical periodontal therapy on clinical and immunological response and glycaemic control in type 2 diabetic patients with moderate periodontitis. J Clin Periodontol 2007;34:835-843.
14. Ikezawa-Suzuki 1, Shimada Y, Tai H, Komatsu Y, Tanaka A, Yoshie H. Effects of treatment on soluble tumour necrosis factor receptor type 1 and 2 in chronic periodontitis. J Clin Periodontol 2008;35:961-968.
15. Ataoglu H, Alptekin NO, Haliloglu S, et al. Interleukin-Ibeta, tumor necrosis factor-alpha levels and neutrophil elastase activity in peri-implant crevicular fluid. Clin Oral Implants Res 2002;13:470-476.
16. Panagakos FS, Aboyoussef H, Dondero R, Jandinski JJ. Detection and measurement of inflammatory cytokines in implant crevicular fluid: A pilot study. Int J Oral Maxillofac Implants 1996; 11:794-799.
17. Machtei EE, Oved-Peleg E, Peled M. Comparison of clinical, radiographic and immunological parameters of teeth and different dental implant platforms. Clin Oral Implants Res 2008;17:858-665.
18. Schierano G, Pejrone G, Brusco P, et al. TNF-alpha TGF-beta2 and IL-1 beta levels in gingival and peri-implant crevicular fluid before and after de novo plaque accumulation. J Clin Periodontol 2008;35:
19. Nowzari H, Botero JE, DeGiacomo M, Villacres MC, Rich SK. Microbiology and cytokine levels around healthy dental implants and teeth. Clin Implant Dent Relat Res 2008;10:188473.
20. Klinge B, Gustafsson A, Berglundh T, A systematic review of the effect of anti-infective therapy in the treatment of peri-implantitis. J Clin Periodontol 2002; 29:213-225.
21. Roos-Jansaker AM, Renvert S, Egelberg J. Treatment of peri-implant infections: A literature review. J Clin Periodontal 2003;30:467-485.
22. Claffey N, Clarke E, Polyzois I, Renvert S. Surgical treatment of peri-implantitis. J Clin Periodontal 2008; 35(Suppl. 8):316-332,
23. Curtis DA, Kao R, Plesh O, Finzen F, Franz L Crevicular fluid analysis around two failing dental implants: A clinical report. J Prosthodont 1997;8:210-214.
24. Araújo MW, Hovey KM, Benedek JR, et al. Reproducibility of probing depth measurement using a constant-force electronic probe: Analysis of inter-and intraexaminer variability. J Periodontol 2003;74: 1736-1740.
25. Ainamo J, Bay I. Problems and proposals for recording gingivitis and plaque, frit Dent J 1975;25:229-235.
26. Lamster IB, Oshrain RL, Gordon JM. Enzyme activity in human gingival crevicular fluid: Considerations in data reporting based on analysis of individual crevicular sites. J Clin Periodontol 1986;13:799-804.
27. Nakashima K, Demeurisse C, Cimasoni G. The recovery efficiency of various materials for sampling enzymes and polymorphonuclear leukocytes from gingival crevices. J Clin Periodontal 1994;21:479-483.
28. Konttinen YT, Lappalainen R, Laine P, Kitti u, Santavirta S, Teronen O. Immunohistochemical evaluation of inflammatory mediators in failing implants. Int J Periodontics Restorative Dent 2006;26:135-141,
29. Tervahartiala T, Koski H, Xu JW, et al. Tumor necrosis factor-alpha and its receptors, p55 and p75, in gingiva of adult periodontitis. J Dent Res 2001;80:1535-1539.
30. Górska R, Gregorek H, Kowalski J, Laskus-Perendyk A, Syczewska M, Madalihski K. Relationship between clinical parameters and cytokine profiles in inflamed gingival tissue and serum samples from patients with chronic periodontitis, J Clin Periodontol 2003:30: 1046-1052.
31. Prat C, Dominguez J, Rodrigo C, et al. Procalcitonin, C-reactive protein and leukocyte count in children with lower respiratory tract infection. Pediatr Infect Dis J 2003;22:963-968.
32. Bottner F, Wegner A, Winkelmann W, Becker K, Erren M, Götze C. Interleukin-6, procalcitonin and TNF-alpha: Markers of peri-prosthetic infection following total joint replacement. J Bone Joint Surg Br 2007; 89:94-99.
33. Schwarz EM, Looney RJ, O'Keefe RJ. Anti-TNF-alpha therapy as a clinical intervention for periprosthetic osteolysis. Arthritis Res 2000;2:185-168.
34. Garrison L, McDonnell ND. Etanercept: Therapeutic use in patients with rheumatoid arthritis. Ann Rheum Dis 1999;58(Suppl. 1):I65-I69.
35. Bradley JR, TNF-mediated inflammatory disease, J Pathol 2008;214:149-160.